CD4 and neoplasm: Thus, tumor Ag reaches the TdLN in sufficient amount to induce activation and proliferation of tumor Ag-specific naive CD4+ T cells, but the resulting priming is not efficient enough to induce full activation and migration of the tumor Ag-specific CD4+ T cells to the tumor site, independently of tumor size.